GPA33 and colorectal cancer: <i>In vivo</i>, using a DOTA-PRIT system targeting the GPA33 antigen in a human colorectal cancer mouse model, [<sup>68</sup>Ga]Ga-NODAGA-Pr demonstrated efficient tumor uptake and high-contrast PET imaging.